Home Company Technology Platform Products and Services Contact
 
Mission
Business
Partners
People
Publications References



Members of the Board

Michael Zang-Gandor: Founder, Chief Executive Officer and President; qualified as molecular biologist and biotechnologist received his MD in 1992 at the University of Weihenstephan and the Swiss Federal Institute of Technology / Zurich. Before he founded EUGENEX he established and ran a molecular and cell biology service lab for protein expression at Novartis AG, Basle.

Christine Gandor, Ph.D.: Co-Founder, CFO; qualified as a cell biologist, obtained her Ph.D. 1993 from the Swiss Federal Institute of Technology in Zurich. At Novartis AG, Basle she improved different expression systems and adapted cell lines for the application in HTS (High Throughput Screening) in biotechnology industry within the framework of the Swiss priority program (SPP).

When Michael Zang-Gandor and Christine Gandor founded EUGENEX they brought a more than 10 years experience with serum- and protein-free cell culture and a broad repertoire of know-how and skills in mammalian cell culture, molecular genetics and gene expression. In 1992 they established the first expression system with protein-free growing CHO (Chinese Hamster ovary) cells at the Institute of Biotechnology, Swiss Federal Institute of Technology, Zurich.

Toni Lindl, Ph.D.: Member of the board; established cell culture methods from the beginning obtained his Ph.D. in 1974 from the University of Freiburg i. Br. He founded and heads the Institute for Applied Cell Culture (IAZ), Munich. Since 1990 he is Professor for biology and cell culture technology at the University of Weihenstephan.

 




copyright EUGENEX Biotechnologies GmbH
 imprint  ·  eMail: info@eugenex.com
 realized by HORNUNG